Table 1. Sociodemographic characteristics of respondents of the monkeypox vaccine acceptance survey, World Health Organization European Region, 30 July–12 August 2022.
| Characteristic | Sample description | Vaccine acceptancea | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Number | %b | Acceptance number |
%c | Hesitancy number |
%c | Refusal number |
% | No answer/ missing number |
%c | |
| Total | 32,902 | 100 | 26,980 | 82 | 2,890 | 8.8 | 2,686 | 8.2 | 346 | 1.1 |
| Median age in years (IQR) | 38 (30–47) | 39 (30–48) | 35 (27–45) | 36 (28–45) | 38 (31–50) | |||||
| Age category in years | ||||||||||
| 18–29 | 7,724 | 23.5 | 5,967 | 77.3 | 915 | 11.8 | 767 | 9.9 | 75 | 1.0 |
| 30–39 | 9,802 | 29.8 | 8,003 | 81.6 | 859 | 8.8 | 827 | 8.4 | 113 | 1.2 |
| 40–49 | 8,549 | 26.0 | 7,220 | 84.5 | 626 | 7.3 | 633 | 7.4 | 70 | 0.8 |
| 50–84 | 6,827 | 20.7 | 5,790 | 84.8 | 490 | 7.2 | 459 | 6.7 | 88 | 1.3 |
| Subregion of residenced | ||||||||||
| Baltics | 131 | 0.4 | 106 | 80.9 | 15 | 11.5 | 10 | 7.6 | 0 | 0.0 |
| Central Europe | 2,628 | 8.0 | 1,760 | 67.0 | 376 | 14.3 | 472 | 18.0 | 20 | 0.8 |
| Eastern Europe | 1,602 | 4.9 | 1,060 | 66.2 | 274 | 17.1 | 249 | 15.5 | 19 | 1.2 |
| Mediterranean Europe | 11,424 | 34.7 | 9,826 | 86.0 | 856 | 7.5 | 686 | 6.0 | 56 | 0.5 |
| Northern Europe | 3,126 | 9.5 | 2,725 | 87.2 | 223 | 7.1 | 164 | 5.2 | 14 | 0.4 |
| South-East Europe | 1,901 | 5.8 | 1,284 | 67.5 | 299 | 15.7 | 302 | 15.9 | 16 | 0.8 |
| Western Europe | 12,090 | 36.7 | 10,219 | 84.5 | 847 | 7.0 | 803 | 6.6 | 221 | 1.8 |
| Migrants | ||||||||||
| No | 27,524 | 83.7 | 22,400 | 81.4 | 2,532 | 9.2 | 2,329 | 8.5 | 263 | 1.0 |
| Yes | 5,378 | 16.3 | 4,580 | 85.2 | 358 | 6.7 | 357 | 6.6 | 83 | 1.5 |
| European subregion or other world region of origind | ||||||||||
| Baltics | 47 | 0.9 | 39 | 83.0 | 3 | 6.4 | 4 | 8.5 | 1 | 2.1 |
| Caribbean | 86 | 1.6 | 75 | 87.2 | 5 | 5.8 | 2 | 2.3 | 4 | 4.7 |
| Central America | 150 | 2.8 | 141 | 94.0 | 2 | 1.3 | 6 | 4.0 | 1 | 0.7 |
| Central Europe | 420 | 7.8 | 312 | 74.3 | 53 | 12.6 | 46 | 11.0 | 9 | 2.1 |
| Eastern Europe | 292 | 5.4 | 209 | 71.6 | 38 | 13.0 | 41 | 14.0 | 4 | 1.4 |
| Eastern Mediterranean | 254 | 4.7 | 212 | 83.5 | 20 | 7.9 | 17 | 6.7 | 5 | 2.0 |
| Mediterranean Europe | 713 | 13.3 | 617 | 86.5 | 45 | 6.3 | 44 | 6.2 | 7 | 1.0 |
| Northern America | 210 | 3.9 | 189 | 90.0 | 8 | 3.8 | 13 | 6.2 | 0 | 0.0 |
| Northern Europe | 130 | 2.4 | 115 | 88.5 | 9 | 6.9 | 6 | 4.6 | 0 | 0.0 |
| South America | 1,241 | 23.1 | 1,157 | 93.2 | 49 | 3.9 | 29 | 2.3 | 6 | 0.5 |
| South-East Asia | 67 | 1.2 | 52 | 77.6 | 9 | 13.4 | 4 | 6.0 | 2 | 3.0 |
| South-East Europe | 315 | 5.9 | 232 | 73.7 | 36 | 11.4 | 44 | 14.0 | 3 | 1.0 |
| Sub-Saharan Africa | 166 | 3.1 | 136 | 81.9 | 14 | 8.4 | 12 | 7.2 | 4 | 2.4 |
| Western Europe | 1,037 | 19.3 | 886 | 85.4 | 58 | 5.6 | 83 | 8.0 | 10 | 1.0 |
| Western Pacific | 155 | 2.9 | 142 | 91.6 | 7 | 4.5 | 3 | 1.9 | 3 | 1.9 |
| Unclear regione | 95 | 1.8 | 66 | 69.5 | 2 | 2.1 | 3 | 3.2 | 24 | 25.3 |
IQR: interquartile range.
a Monkeypox vaccine acceptance and hesitancy were measured by how many respondents agreed with the following statement: ‘If the vaccine for monkeypox is offered to you, will you get vaccinated?’ A five-point Likert-type rating scale was used with the following range of choices: ‘I will get vaccinated, probably yes, not sure, probably not, I won’t get vaccinated, I don’t want to answer.’ Those who chose ‘I will get vaccinated’ or ‘Probably yes’ were defined as accepting. Those who chose ‘not sure’ were defined as hesitant. Those who chose ‘probably not’ or ‘I won’t get vaccinated’ were defined as refusal (Supplementary Material S3 for sample description for the whole five-point Likert-type rating scale).
b The denominator of the percentages is the total sample for all characteristics apart from the region of origin, for which the denominator is the total number of migrant respondents.
c The percentage is calculated based on the total number of participants in the same sub-category (i.e. second column of the table on the same row).
d The countries considered in each European subregion are described in the Supplementary Material sections S1 and S2. Countries considered in regions outside of Europe are described in Supplementary Material S2.
e The region was not clearly identifiable from the respondent answer.